Summit Pharma Resources
Technology & Internet · Lobbying Client
C
Influence Score
41/100
Moderate Influence
$2.3M
Total Lobby Spend
4
Policy Issues
1
Lobbyists
0
Revolving Door
Summit Pharma Resources reported $2.3 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 4 policy areas, with primary focus on Computer Industry, Telecommunications, Copyright/Patent/Trademark. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Dept of Interior
Securities & Exchange Commission
Federal Aviation Administration
Dept of Energy
US Senate
US House of Representatives
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | K&L Gates LLP | TECGOV | 1 | $108K |
| 2020 Apr-Jun | BGR Group LLP | CPITECGOV+1 | 1 | $87K |
| 2020 Jul-Sep | Akin Gump LLP | CPT | 1 | $115K |
| 2020 Oct-Dec | Cassidy & Associates LLP | CPITEC | 1 | $131K |
| 2021 Jan-Mar | BGR Group LLP | TECCPI | 1 | $89K |
| 2021 Apr-Jun | Squire Patton Boggs LLP | TEC | 1 | $125K |
| 2021 Jul-Sep | BGR Group LLP | CPTCPI | 1 | $118K |
| 2021 Oct-Dec | K&L Gates LLP | CPICPTGOV+1 | 1 | $97K |